Kent; John S.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Kent; John S..The latest application filed is for "implant stent with a retinoid for improved biocompatibility".

Company Profile

0.16.5

Kent; John S. - Newport Beach CA
Kent; John S. - Newport Coast CA
Kent; John S. - Palo Alto CA
Kent; John S. - Cupertino CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Implant Stent With A Retinoid For Improved Biocompatibility App 20080213338 - Olejnik; Orest ; et al.	2008-09-04
Implant device with a retinoid for improved biocompatibility Grant 7,384,648 - Olejnik , et al. June 10, 2	2008-06-10
Implant device with a retinoid for improved biocompatibility Grant 7,179,482 - Olejnik , et al. February 20, 2	2007-02-20
Implant device with a retinoid for improved biocompatibility App 20050142165 - Olejnik, Orest ; et al.	2005-06-30
Implant device with a retinoid for improved biocompatibility App 20040219187 - Olejnik, Orest ; et al.	2004-11-04
Implant device with a retinoid for improved biocompatibility Grant 6,743,437 - Olejnik , et al. June 1, 2	2004-06-01
Implant device with a retinoid for improved biocompatibility App 20030185875 - Olejnik, Orest ; et al.	2003-10-02
Implant device with a retinoid for improved biocompatibility Grant 6,537,568 - Olejnik , et al. March 25, 2	2003-03-25
Implant device with a retinoid for improved biocompatibility Grant 6,455,062 - Olejnik , et al. September 24, 2	2002-09-24
Storage and delivery of multi-dose, preservative-free pharmaceuticals Grant 6,450,994 - Boyles , et al. September 17, 2	2002-09-17
Implant device with a retinoid for improved biocompatibility App 20020022047 - Olejnik, Orest ; et al.	2002-02-21
Implant device with a retinoid for improved biocompatibility Grant 6,306,426 - Olejnik , et al. October 23, 2	2001-10-23
Sterile bioerodible implant device with a retinoid for improved biocompatability Grant 6,110,485 - Olejnik , et al. August 29, 2	2000-08-29
Sterile bioerodible occular implant device with a retinoid for improved biocompatability Grant 6,074,661 - Olejnik , et al. June 13, 2	2000-06-13
Controlled release naproxen and naproxen sodium tablets Grant 4,803,079 - Hsiao , et al. * February 7, 1	1989-02-07
Microencapsulation of water soluble active polypeptides Grant 4,675,189 - Kent , et al. June 23, 1	1987-06-23
Controlled release naproxen and naproxen sodium tablets Grant 4,571,333 - Hsiao , et al. February 18, 1	1986-02-18
Cholesterol matrix delivery system for sustained release of macromolecules Grant 4,452,775 - Kent June 5, 1	1984-06-05
Prostaglandin compositions Grant 4,389,414 - Kent June 21, 1	1983-06-21
Inert core implant pellet Grant 4,180,560 - Katz , et al. * December 25, 1	1979-12-25
Inert core implant pellet Grant 4,096,239 - Katz , et al. June 20, 1	1978-06-20

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.